Adapting to FDA Workforce Reductions and Regulatory Delays in 2025: Strategies for Bioscience Companies
Introduction The U.S. Food and Drug Administration (FDA) is facing a significant shake-up with a recent workforce reduction of approximately 3,500 positions as part of…
